Assignee
AP BIOSCIENCES INC
TW·7 granted patents·6 pending applications·13 citations·filing 2012–2025
Top patents by PatentIndex Score
13 records- 0185US9988611B2Protein inhibitors to complement and VEGF pathways and methods of use thereofAP BIOSCIENCES INC·Filed 2012·Granted Jun 5, 2018·10 cites·41 claims
- 0279US11780922B2Bifunctional proteins combining checkpoint blockade for targeted therapyAP BIOSCIENCES INC·Filed 2020·Granted Oct 10, 2023·1 cites·15 claims
- 0378US12312409B2Bispecific CD137-binding antibodies for T-cell activationAP BIOSCIENCES INC·Filed 2023·Granted May 27, 2025·0 cites·9 claims
- 0478US12304961B2PD-L1 and OX40 binding proteins for cancer regulationAP BIOSCIENCES INC·Filed 2023·Granted May 20, 2025·0 cites·19 claims
- 0577US11518984B2Protein inhibitors to complement and VEGF pathways and methods of use thereofAP BIOSCIENCES INC·Filed 2018·Granted Dec 6, 2022·2 cites·29 claims
- 0672US2025346678A1OX40 Binding Proteins for Cancer RegulationAP BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0772US2023322931A1Bifunctional Proteins Combining Checkpoint Blockade for Targeted TherapyAP BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0871US2025270338A1Antibodies for t-cell activationAP BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0966US11643470B2PD-L1 and OX40 binding proteins for cancer RegulationAP BIOSCIENCES INC·Filed 2020·Granted May 9, 2023·0 cites·27 claims
- 1066US2025154273A1PD-L1 and OX40 Binding Proteins for Cancer RegulationAP BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1164US11725058B2CD137 antibodies for T-cell activationAP BIOSCIENCES INC·Filed 2020·Granted Aug 15, 2023·0 cites·12 claims
- 1259US2024391976A1Bi-Functional Fusion Proteins to Complement Pathways and Method of Inhibiting Bone ResorptionAP BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1359US2025026841A1Bispecific antibodies targeting cd137 and uses thereof for anti-cancer immunotherapyAP BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →